Bank of America just raised its EUR/USD forecast
Cathie Wood’s ARK ETFs have reported their daily trades for Monday, April 14th, 2025, showcasing a mix of strategic buys and sells across the technology and defense sectors. The most significant transaction of the day involved the sale of 141,236 shares of UiPath Inc (NYSE:PATH), a leading enterprise automation software company, spread across ARKK, ARKW, and ARKF ETFs, with a total dollar value of $1,535,235.
Following this, ARK’s ARKX (NYSE:ARKX) ETF offloaded a considerable number of shares in Kratos Defense and Security Solutions Inc (NASDAQ:KTOS), a company specializing in unmanned systems, satellite communications, and defense solutions, totaling 34,512 shares valued at $1,147,178.
On the buying front, ARK’s most substantial investment was in Recursion Pharmaceuticals Inc (NASDAQ:RXRX), acquiring 460,044 shares through its ARKK ETF, amounting to $2,649,853. This move indicates ARK’s growing interest in the biotechnology company focused on digitizing drug discovery.
In the aerospace sector, ARKX ETF added 3,547 shares of AeroVironment Inc (NASDAQ:AVAV), a manufacturer of unmanned aircraft systems and tactical missile systems, for a total of $519,032. This purchase suggests a continued bullish stance on the aerospace industry, as ARK had previously bought shares of AeroVironment earlier in the month.
Additionally, ARKX ETF increased its holdings in Iridium Communications Inc (NASDAQ:IRDM) by purchasing 10,389 shares worth $252,141. Iridium operates a satellite constellation providing voice and data coverage to satellite phones, pagers, and integrated transceivers over the Earth’s entire surface.
L3Harris Technologies Inc (NYSE:LHX), an American technology company, defense contractor, and information technology services provider, also saw an inflow of capital as ARKX ETF bought 1,711 shares valued at $379,893.
In smaller transactions, ARK sold 114 shares of Prime Medicine Inc (NASDAQ:PRME) through its ARKK ETF for a modest $151 and divested 311,668 shares of Repare Therapeutics Inc (NASDAQ:RPTX) through its ARKG ETF, totaling $280,501.
Looking at recent trade patterns, ARK has consistently reduced its position in UiPath Inc (NYSE:PATH) over the past week, indicating a possible shift in their investment strategy regarding the automation software company. Conversely, the consistent buying of AeroVironment Inc (NASDAQ:AVAV) and Iridium Communications Inc (NASDAQ:IRDM) shares suggests a growing confidence in these companies.
Investors should note that these trades reflect ARK’s active management approach and their investment strategies can change based on market conditions and company performance. As always, individual investors should conduct their own research or consult with financial advisors before making investment decisions based on these trades.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.